Our previous study on type 1 diabetes demonstrated that SUMOylation positively regulates key metabolic enzymes, including Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), citrate synthase, and transketolase-like protein-1 (TKTL1), within the Krebs cycle. Here, GAPDH is linked to type 1 diabetes mellitus.